Feng Zhu

Dr. Feng Zhu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Medicine
Verified
Journal Article
Open access
FZFeng Zhu
Feng Zhu
YZYan Zhang
Yan Zhang
LSLei Shi
Lei Shi
CWChun-Lei Wu
Chun-Lei Wu
SCShuai-Qi Chen
Shuai-Qi Chen
DSDongkui Song
Dongkui Song
Early diagnose of bladder cancer could lead to good prognosis and high 5-year-survival rate. Among bladder cancer, about 75% patients with were nonmuscle-invasive bladder cancer (NMIBC). Patients were painful and easily get infected during bladder cancer diagnosis, which mainly depends on invasive cystoscopy and low-sensitivity urine exfoliation cytology. Meanwhile, relapse after surgery was also becoming the major problem for patients. Exploring noninvasive, high-sensitivity, and painless method is very important and meaningful for NMIBC treatment. Firstly, we found potential related gene mutation sites for NMIBC by searching COSMIC database and related study. Urinary sediment cells of patients both in normal group (patients with benign) and NMIMC group were collected before and after operation for potential gene mutation site detecting. Meanwhile, the urinary sediment cells of relapse patients and good prognosis people in NMIBC group after surgery were also collected for further Gene mutation detection and NMIBC relapse after surgery prediction. Fourteen genes (152 mutation sites) were selected between 95 NMIBC patients and 67 control patients, which were FGFR3, TP53, PIK3CA, and others. Compared with control group, mutation ratio of above 14 genes was higher in NMIBC group. NMIBC diagnose model was established by 5 times cross-validation and had a good effects, which included the all mutation site in FGFR3, TP53, PIK3CA, ARID1A, STAG2, and KTM2D. On the contrary, the relapse rate was 30.5% among 95 patients for about 1.5-year follow-up time. Compared with control group, smoking rate and tumor grade were higher in relapse group. Meanwhile, mutation rate of FGFR3, TP53, PIK3CA, ERBB3, and TSC1 in relapse group were higher than that in normal group. According to the mutation sites of FGFR3, TP53, PIK3CA, and ERBB3 and the combination of urinary sediment cells genetic mutation and relapse status, a predicted model for NMIBC relapse was also established, which had 90% accuracy. The diagnosed NMIBC model (based on FGFR3, TP53, PIK3CA, ARID1A, STAG2, and KTM2D gene mutation) and predicted relapse model (based on FGFR3, TP53, PIK3CA, and ERBB3 gene mutation) possess high accuracy and would be applied in early diagnose and early predicting relapse of patients.

3 May 2023 in Cancer Medicine
Verified
Journal Article
Open access
FZFeng Zhu
Feng Zhu
FLFuqiang Li
Fuqiang Li
XXXiaojun Xie
Xiaojun Xie
YWYijun Wu
Yijun Wu
WWweilin wang
weilin wang
Background: The purpose of the study was to investigate the ability of new parameters in distinguishing high‐risk patients of recurrence from isthmic papillary thyroid carcinomas (iPTCs).Methods: One hundred sixteen iPTC patients who underwent total thyroidectomy were identified from 3461 PTC patients from 2014 to 2019. Tumor margin to trachea midline distance (TTD), maximum tumor size (TS), and transverse diameter of trachea (TD) were measured on CT images. Cox proportional hazard models served to identify risk factors associated with recurrence‐free survival (RFS). The iPTC prognostic formula (IPF = TD/(TTD − TS) − TD/TTD) was evaluated to assess the prognosis. RFS was conducted between the different groups using the Kaplan–Meier analysis. The receiver operating characteristic (ROC) curve of each parameter was drawn to predict recurrence.Results: Central lymph node metastasis (CLNM) and extrathyroidal invasion in iPTC were 58.6% and 31.0%, respectively. Regional recurrence occurred in 16 (13.8%) patients, and no patient died or had distant metastasis. The 3‐ and 5‐year RFS of iPTC were 87.5% and 84.5%, respectively. Gender (p = 0.001) and PLNM (prelaryngeal lymph node metastasis) (p = 0.010) in cPTC (center of iPTC located between two imaginary lines perpendicular to the surface of the skin from the most lateral points of the trachea) and non‐cPTC (iPTC patients enrolled in this study excluding cPTC) groups differed significantly. A cut‐off point of tumor size >1.1 cm and IPF ≤5.57 were established to have significant differences in prognosis (p = 0.032 and p = 0.005, respectively). Multivariate analysis showed that IPF ≤5.57 was independent prognostic factor for RFS (HR: 4.415, 95%CI: 1.118–17.431, p = 0.034).Conclusion: This study indicated the association between IPF and RFS in iPTC patients and established new models to assess risk factors for recurrence pre‐operation. IPF ≤5.57 was significantly associated with poor RFS and might be promising parameters for predicting prognosis and surgical decision‐making pre‐operation.

7 June 2023 in International Journal of Surgery
Verified
Journal Article
Open access
LCLinghui Chen
Linghui Chen
QHQiwen He
Qiwen He
HTHedi Tian
Hedi Tian
QZQinsheng Zhu
Qinsheng Zhu
YSYibin Shen
Yibin Shen
YWYijun Wu
Yijun Wu
Background: Surgery is still the most important treatment method for thyroid cancer. The classic linea alba cervicalis approach caused obvious neck scarring. This study explored an alternative open operative approach with concealed incision for hemithyroidectomy, and demonstrated whether it was non-inferior to traditional approach in postoperative complications and operation efficiency. Methods: Patients (n=220) from November 2019 to November 2020 willing to undergo hemithyroidectomy because of differentiated thyroid cancer were randomly divided into the sternocleidomastoid intermuscular approach (SMIA) group (n=110), and the linea alba cervicalis approach (LACA) group (n=110). The incidence of postoperative complications within 3 months and operation efficiency indicator R0 resection rate were recorded as primary endpoint, while scar apperance was assessed as secondary endpoint. The data were statistically analyzed. Results: The baseline data of these two groups were comparable, with no significant difference (P>0.05). As primary endpoint, R0 resection rate was 100% in both groups. In the 1-month follow-up period, the SMIA group had a lower score for neck discomfort compared with that of the LACA group (1.01±0.1648 vs. 0.5657±0.0976, P=0.0217). The SMIA group’s scar had better results from the observer scar assessment compared to that of the LACA group as secondary endpoint. Within the 3-month follow-up, the total complications were calculated, and it was demonstrated that SMIA was non-inferior to traditional LACA operation (P of non-inferiority=0.0048). Conclusions: Compared with LACA group, surgery through the SMIA is safe, effective, and has non-inferior postoperative complications. SMIA can be considered an alternative approach to classic LACA in hemithyroidectomy.

20 June 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
FZFeng Zhu
Feng Zhu
YSYibin Shen
Yibin Shen
LZLixian Zhu
Lixian Zhu
LCLinghui Chen
Linghui Chen
FLFuqiang Li
Fuqiang Li
YWYijun Wu
Yijun Wu
Background: Involvement of the recurrent laryngeal nerve (RLN) in papillary thyroid carcinoma (PTC) is an important prognostic factor and is associated with a higher risk of recurrence. This study aimed to retrospectively analyze the outcomes of patients treated with hemithyroidectomy (HT) in PTC patients with an exclusive RLN invasion who could not tolerate staged surgery, did not wish to undergo another operation, or had other reasons. Methods: A retrospective review was conducted on 163 patients with PTC and exclusive RLN involvement at our institution between 2013 and 2019. Patients were divided into a total thyroidectomy (TT) group and HT group. The clinicopathologic factors and prognostic outcomes were compared between the two groups. A propensity score-matched analysis was carried out to reduce selection bias, with the following covariates: gender, age, tumor size, multifocality, central lymph node metastasis (CLNM), and RLN resection. The Kaplan–Meier method was used for a comparison of recurrence outcomes. Results: In the baseline data of the 163 PTC patients, tumor size (p < 0.001), multifocality (p = 0.011), CLNM (p < 0.001), and RLN resection (p < 0.008) in the TT and HT groups differed significantly, whereas age and gender did not differ between the two groups. The TT group reported significantly higher temporary and permanent hypoparathyroidism than the HT group (p < 0.001 and p = 0.042, respectively). With 72-month median follow-up, 11 (6.7%) patients developed recurrence. After propensity score matching, 24 patients with HT and 43 patients with TT were included. Recurrence-free survival (RFS) in the matched samples showed no difference between the TT and HT groups (p = 0.092). Conclusion: Our results indicate that HT may be a feasible treatment for PTC patients with exclusive RLN involvement in specific circumstances without significantly increasing the risk of recurrence. Performing a thorough preoperative examination is crucial to exclude multifocal tumors and lymph node metastasis before undergoing HT.

1 April 2026 in Gland Surgery
Verified
Journal Article
Open access
PDF file
FZFeng Zhu
Feng Zhu
LZLi-Xian Zhu
Li-Xian Zhu
YSYi-Bin Shen
Yi-Bin Shen
MLMeng-Xia Li
Meng-Xia Li
XXXiao-Jun Xie
Xiao-Jun Xie
YWYijun Wu
Yijun Wu
Background: The optimal surgical extent for isthmic papillary thyroid microcarcinoma (iPTMC) remains controversial. This study aimed to compare the oncological and surgical outcomes of isthmusectomy (IT) and lobectomy (LT) in patients with clinically node-negative (cN0) solitary iPTMC. Methods: We retrospectively analyzed 303 consecutive patients with cN0 solitary iPTMC who underwent thyroid surgery between 2017 and 2024. Patients with multifocal disease, tumor size >1 cm, clinically positive lymph nodes, gross extrathyroidal extension (gETE), non-PTC pathology, prior neck irradiation, or reoperative thyroid surgery were excluded. Baseline clinicopathologic variables, including age, sex, tumor size, central lymph node metastasis (CLNM), microscopic extrathyroidal extension (mETE), and recurrence were collected and compared between the IT and LT groups. Postoperative complications and levothyroxine requirements were evaluated. Propensity score matching (PSM) was performed to minimize selection bias. Patients were routinely followed up at 3–6-month intervals with ultrasonography (US) and assessment of thyroid function. Recurrence-free survival (RFS) was analyzed using the Kaplan-Meier method. Results: Among the 303 patients, 96 underwent IT and 207 underwent LT. Before PSM, baseline characteristics were comparable between groups, including age, sex, tumor size, CLNM, and mETE. After 1:2 PSM, 85 IT patients were matched with 146 LT patients, and baseline characteristics remained well balanced between the groups. The IT group had a significantly higher median number of dissected central lymph nodes (CLNs) and a shorter operative time (P<0.001 and P<0.001, respectively). Transient hoarseness was more frequent in the LT group (5.8% vs. 0%), while hypocalcemia rates were comparable. The median levothyroxine dose was significantly higher in the LT group (P<0.001). Recurrence occurred in 4.2% of the IT group and 3.4% of the LT group, with no statistically significant difference (P=0.73). Kaplan-Meier curves showed that RFS was comparable between the groups both before (P=0.12) and after PSM (P=0.10). Multivariate analysis showed that the CLNM was independent predictor of poor RFS (P=0.007). Conclusions: Preliminary findings from this retrospective analysis suggest that isthmusectomy could be a viable, tissue-preserving alternative for selected iPTMC patients, potentially reducing levothyroxine requirements and postoperative complications. However, given the inherent selection bias, these results should be interpreted with caution. Furthermore, considering the high incidence of occult CLNM, the necessity of prophylactic CLN dissection warrants further validation in prospective studies.